Medicine for treating white lesions of vulva and preparation method thereof

A technology for vulvar white lesions and drugs, which is applied in the directions of drug combinations, pharmaceutical formulations, and non-active ingredients medical preparations, etc., can solve the problems of slow effect, long treatment course, poor public and public conditions, etc., and achieves rigorous formulation and effective results. Fast, long-lasting results

Pending Publication Date: 2018-10-26
李淑玲
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In view of the many disadvantages of western medicine in the treatment of vulvar white lesions, there are also cases of using traditional Chinese medicine for treatment. However, due to the unique characteristics of long treatment period and slow effect of traditional Chinese medicine, the patients still suffer from various discomforts for a long time.
Cui Liqun (Exploring the clinical value of hypocretin ointment in treating vulvar leukoplakia [J]. China Health Standard Management, 2017, 8(20): 108-109.) using hypocrellin ointment in the treatment of vulvar leukoplakia, the curative effect is still low. Yes, but the known public situation is poor

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for treating white lesions of vulva and preparation method thereof
  • Medicine for treating white lesions of vulva and preparation method thereof
  • Medicine for treating white lesions of vulva and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] A medicine for treating white lesions of the vulva, the active ingredients of which are made of the following raw materials: 450g of white fresh skin, 150g of nystatin, 50g of dyclonine hydrochloride, 20g of dexamethasone, 10g of borneol, 5g of phenergan, Chloramphenicol powder 85g, hydrophilic cream base II 230g;

[0022] The above-mentioned hydrophilic cream base II is made of the following raw materials by weight:

[0023] Stearic acid 113g, glycerol monostearate 70g, glycerin 55g, white petrolatum 85g, sodium lauryl sulfate 10g, ethyl p-hydroxybenzoate 1g, add purified water to 1000g.

[0024] The preparation method of the above-mentioned medicine for the treatment of vulva white lesions comprises the following steps:

[0025] (1) According to the above weight, take nystatin, dyclonine hydrochloride, dexamethasone, borneol, chloramphenicol powder and phenergan, add 25.6g of ethanol to dissolve to obtain the medicinal solution; take 230g of hydrophilic cream base I...

Embodiment 2

[0029] A medicine for treating white lesions of the vulva, the active ingredients of which are made of the following raw materials: 440g of white fresh skin, 140g of nystatin, 40g of dyclonine hydrochloride, 10g of dexamethasone, 8g of borneol, 4g of phenergan, Chloramphenicol powder 75g, hydrophilic cream base II 220g;

[0030] The composition of the above-mentioned hydrophilic cream base II is the same as that of the hydrophilic cream base II in Example 1.

[0031] The preparation method of the above-mentioned medicine for the treatment of vulva white lesions comprises the following steps:

[0032] (1) According to the above weight, take nystatin, dyclonine hydrochloride, dexamethasone, borneol, chloramphenicol powder and phenergan, add 8.31g of ethanol to dissolve to obtain a medicinal solution; take 220g of hydrophilic cream base II. When the temperature of the hydrophilic cream base II drops below 50°C, mix the above-mentioned medicinal solution with the hydrophilic crea...

Embodiment 3

[0036] A medicine for treating white lesions of the vulva, the active ingredients of which are made of the following raw materials: 460g of white fresh skin, 160g of nystatin, 60g of dyclonine hydrochloride, 30g of dexamethasone, 12g of borneol, 6g of phenergan, Chloramphenicol powder 95g, hydrophilic cream base II 240g;

[0037] The composition of the above-mentioned hydrophilic cream base II is the same as that of the hydrophilic cream base II in Example 1.

[0038] The preparation method of the above-mentioned medicine for the treatment of vulva white lesions comprises the following steps:

[0039] (1) According to the above weight, take nystatin, dyclonine hydrochloride, dexamethasone, borneol, chloramphenicol powder and phenergan, add 47.2g of ethanol to dissolve to obtain the medicinal solution; get 240g of hydrophilic cream base II. When the temperature of the hydrophilic cream base II drops below 50°C, mix the above-mentioned medicinal solution with the hydrophilic cr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a medicine for treating white lesions of vulva and a preparation method thereof. The medicine for treating white lesions of vulva is prepared from cortex dictamni, nystatin, dyclonine hydrochloride, dexamethasone, borneol, phenergan, chloromycetin powder and hydrophilic cream base II by virtue of special preparation steps. The medicine for treating white lesions of vulva is capable of treating both symptoms and root causes and small in toxic and side effects, provides a novel thought and novel method for treating the white lesions of vulva, and has wide clinical application value.

Description

technical field [0001] The invention relates to a medicine for treating vulva white lesions and a preparation method thereof. Background technique [0002] White lesions of the vulva, also known as chronic vulvar dystrophy, is a group of chronic diseases in which the skin and mucous membranes of the vulva undergo degeneration and pigmentation changes. It often causes severe and unbearable itching of the vulva, and chronic illness causes vulva atrophy, often accompanied by narrow vaginal opening and pain during sexual intercourse, which seriously affects the physical and mental health of patients. So far, the etiology of the disease is not very clear. In recent years, many scholars have done a lot of research on the etiology and pathogenesis of the disease, and believe that many factors are low or obstacles, such as hormone changes, enzyme changes, autoimmune disorders and other factors are the reasons for the occurrence of this disease. At the same time, the pathological a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/75A61K9/06A61P15/02A61P17/00A61P17/04A61K31/7048A61K31/4453A61K31/573A61K31/045A61K31/5415A61K31/165
CPCA61K9/06A61K31/045A61K31/165A61K31/4453A61K31/5415A61K31/573A61K31/7048A61K36/75A61K47/14A61K47/20A61K2236/333A61K2236/39A61P15/02A61P17/00A61P17/04A61K2300/00
Inventor 李淑玲顾一珠王哲万鹏飞王钰童李雅琳
Owner 李淑玲
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap